SCHEMBL1264248

SCHEMBL1264248

COC(OC)C(C)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4386797 0.69
SCHEMBL10948246 0.69
SCHEMBL9259032 0.69
SCHEMBL15011984 0.64
SCHEMBL317946 0.64
SCHEMBL2698450 0.64
SCHEMBL9242325 0.64
SCHEMBL27514356 0.62
SCHEMBL10704298 0.60
SCHEMBL65044 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9017673-B2 Peptide analogues comprising at least one type of aminoacylaza-$g(b)&lt;sp&gt;3&lt;/sp&gt;and the use thereof, in particular for therapy CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2015-04-28 US disclosed
US-20110044974-A1 Peptide analogues comprising at least one type of aminoacylaza-$g(b)&lt;sp&gt;3&lt;/sp&gt;and the use thereof, in particular for therapy CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-02-24 US disclosed
EP-1631586-B1 PEPTIDE ANALOGUES COMPRISING AT LEAST ONE TYPE OF AMINOACYL AZA-BETA 3 AND THE USE THEREOF, IN PARTICULAR FOR THERAPY CENTRE NAT RECH SCIENT (FR) 2007-08-22 EP disclosed